WO2001089503A1 - Composition de traitement contre les parasites - Google Patents

Composition de traitement contre les parasites Download PDF

Info

Publication number
WO2001089503A1
WO2001089503A1 PCT/US2001/016367 US0116367W WO0189503A1 WO 2001089503 A1 WO2001089503 A1 WO 2001089503A1 US 0116367 W US0116367 W US 0116367W WO 0189503 A1 WO0189503 A1 WO 0189503A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
concentration
agent
citronellyl
surfactant
Prior art date
Application number
PCT/US2001/016367
Other languages
English (en)
Inventor
Jeffrey H. Ping
Original Assignee
Effcon Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Effcon Laboratories, Inc. filed Critical Effcon Laboratories, Inc.
Priority to AU2001274877A priority Critical patent/AU2001274877A1/en
Priority to US10/276,657 priority patent/US7282211B2/en
Publication of WO2001089503A1 publication Critical patent/WO2001089503A1/fr
Priority to US11/775,641 priority patent/US7902256B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/02—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings containing insect repellants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N49/00—Biocides, pest repellants or attractants, or plant growth regulators, containing compounds containing the group, wherein m+n>=1, both X together may also mean —Y— or a direct carbon-to-carbon bond, and the carbon atoms marked with an asterisk are not part of any ring system other than that which may be formed by the atoms X, the carbon atoms in square brackets being part of any acyclic or cyclic structure, or the group, wherein A means a carbon atom or Y, n>=0, and not more than one of these carbon atoms being a member of the same ring system, e.g. juvenile insect hormones or mimics thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids

Definitions

  • the present invention relates to agents and methods for the treatment of pest infestations.
  • the invention relates to compositions for cleansing individuals infested with parasites, such as lice, and their ova.
  • Pesticides and insects repellents have long been sought for use against harmful or annoying parasites. Pests such as lice and fleas are irritating and painful to their human and animal hosts, and can also be vectors for other agents of disease.
  • the pesticides and repellents available in the prior art suffer from various deficiencies. Often, compositions provided as insect repellents are not insecticidal. Furthermore, many compositions are either toxic or generally unpleasant to the host. Still others require too many separate active ingredients for efficient production and regulation. Many synthetic prior art compositions have been proposed as insect repellents, but have later been determined to be unsuitable for safe use by humans.
  • One common active ingredient in prior commercial compositions is N,N-Diethyl-m-toluamide (DEET).
  • DEET was subsequently associated with causing various undesirable side- effects, such as stinging, damage to mucous membranes, and possibly seizures.
  • the Centers for Disease Control issued a cautionary statement regarding the use of DEET.
  • Many other prior art compounds proposed for use as a repellent have proven unsuitable for topical application to humans or other animals due to their toxic or noxious effect on the infested individual.
  • composition should also be able to cleanse an individual being treated for infestation.
  • the present invention provides a pediculicidal and ovicidal composition containing an active ingredient which demonstrates an extraordinarily lethal effectiveness against parasites, such as lice and their nits.
  • the pediculicidal and ovicidal composition of the present invention is effective in cleansing an individual, human or animal, of a pest infestation.
  • the composition of the present invention contains an active pediculicidal agent which is at least one purified derivative of an organic oil.
  • These organic oils are typically comprised of a mixture of terpenes.
  • An example of an organic oil from which these compounds can be derived is citronella oil.
  • These purified derivatives can be both pediculicidal and ovicidal.
  • Examples of purified derivatives of citronella oil include citronellal, citronellol and citronellyl based compounds. Purified nerol and geraniol are found in and can also be derived from citronella oil.
  • Another example of an organic oil from which a terpene compound can be derived is teatree oil.
  • the pediculicidal and ovicidal composition preferably contains an active agent present in a concentration of about 0.1 to 50 % w/w.
  • the pediculicidal and ovicidal composition more preferably comprises a citronellyl "salt.”
  • the compositions can be administered topically to humans, animals or to any infested areas.
  • the present invention also includes a method of using the pediculicidal and ovicidal compositions.
  • the method includes applying the composition to the infested area, allowing the composition to remain in contact with the infested area for a period of time, rinsing the composition from the area and, in the case of an infestation of hair such as a lice infestation, combing the infested area with a suitable nit comb.
  • the method also includes varying the period of time the composition is allowed to remain in contact with the infested area, called the residence or exposure time, so that lower concentrations of active ingredient can be used while pediculicidal and ovicidal effectiveness is maintained.
  • the residence time can be increased when a composition containing a lower concentration of the active ingredient is used in the treatment method.
  • composition that may be used as a cleansing shampoo, soap, cream, lotion, gel, spray, mousse or powder.
  • Another object of the present invention is to provide a method of using a pediculicidal and ovicidal composition to cleanse an individual of a pest infestation.
  • a “pest” is meant to include all parasites, such as but not limited to arthropods, arachnids, triatomes, insects, bugs, flies, lice, fleas, mites, gnats, nits, chiggers, mosquitoes, and ticks, for example.
  • the composition of the present invention is, therefore, intended to be used against all parasites which succumb to the lethal properties thereof.
  • the present invention provides a pediculicidal and ovicidal composition
  • a pediculicidal and ovicidal composition comprising or consisting essentially of an active purified terpene agent, a short chain organic alcohol, and a component selected from a non-aqueous co-solvent or surfactant, or combinations thereof.
  • composition can also contain an appropriate viscosity modifier.
  • the present invention provides pediculicidal and ovicidal compositions comprising an active purified terpene agent.
  • the active agent can be at least one purified derivative of an organic oil.
  • purified derivatives of citronella oil can be used as active agents in pediculicidal and ovicidal compositions.
  • derivatives purified from citronella oil include citronellal, citronellol and citronellyl compounds. Other examples include nerol and geraniol.
  • Citronellal, citronellol and citronellyl compounds are currently available in the trade as food and cosmetic additives.
  • the pesticidal agent utilized is citronellyl.
  • the citronellyl compound is selected from the group consisting of citronellyl acetate, citronellyl butyrate, citronellyl formate, citronellyl isobutyrate, citronellyl phenylacetate, citronellyl proprionate and citronellyl valerate.
  • the citronellyl "salt" is the acetate.
  • a highly purified, pharmaceutical grade of citronellyl acetate may be available from Delmar Chemicals (Montreal, Canada).
  • purified herein is meant that the compound of interest is present in the active agent component ofthe composition in a purity or quantity at least 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99% w/w.
  • the invention preferably provides a pediculicidal and ovicidal composition wherein the active purified terpene agent, for example citronellyl, is in a concentration of between about 0.1% and 50%, preferably between about 1% and 40%, preferably between about 2.5% and 30%, preferably between about 5% and 15%, preferably between about 10%) and 15% w/w, and preferably about 12.5% w/w.
  • the active purified terpene agent for example citronellyl
  • compositions also contain a short chain organic alcohol defined as an alcohol having a carbon chain of from 1 to 6 carbon atoms.
  • the short chain alcohol such as but not limited to ethanol or isopropanol, is incorporated in a concentration of between about 5% and 99.5%), preferably between about 10% and 30% w/w, preferably between about 15% and 25%, and preferably between about 20% w/w.
  • compositions also contain a component selected from the group consisting of a non-aqueous co-solvent and a surfactant.
  • the non- aqueous solvent can be selected from compounds such as but not limited to propylene glycol, butylene glycol, polyethylene glycol, hexylene glycol, methoxypolyethylene glycol, or glycerin.
  • the surfactant can be an ionic surfactant, such as but not limited to sodium laureth sulfate (available as STEOL) or sodium lauryl sulfate, or the surfactant can be a non-ionic surfactant such as but not limited to polyoxyethylene sorbitan monolaurate, or polysorbate (available as TWEEN or SPAN), or combinations thereof.
  • This non-aqueous co-solvent and/or surfactant component can be in a concentration of between about 5% and 99.5%, preferably between about 40% and 95%, preferably between about 50% and 90%, preferably between about 55% and 80%, preferably between about 60% and 70%, and preferably about 65% w/w.
  • compositions also optionally contain a thickening agent to achieve an effective viscosity, such as described below, such as but not limited to hydroxypropyl celluose (non-ionic), and acrylates/C 10-30 alkyl acrylate crosspolymers (ionic) (available as PEMULIN), polyvinylpyrrolidone (PVP), polyvinyl alcohol (PVA) (CarbopolTM) and combinations thereof in a concentration of between about 0.01% and 20% w/w, more preferably between about 0.1% and 10% w/w, depending upon the type of thickening agent.
  • a neutralizing agent such as or triethanolamine or sodium hydroxide may also be incorporated for thickening of ionic agents.
  • Some embodiments of the present invention can also include an anti-oxidant/radical scavenging agent, such as but not limited to ascorbic acid (vitamin C) and its salts, tocopherol (vitamin E), and its derivatives such as tocopherol sorbate, other esters of tocopherol, and butylated hydroxy benzoic acids and their salts, such as butyl hydroxytoluene, in order to assist in the removal of pests and their ova.
  • an anti-oxidant/radical scavenging agent such as but not limited to ascorbic acid (vitamin C) and its salts, tocopherol (vitamin E), and its derivatives such as tocopherol sorbate, other esters of tocopherol, and butylated hydroxy benzoic acids and their salts, such as butyl hydroxytoluene, in order to assist in the removal of pests and their ova.
  • a preferred antioxidant/radical scavenging agent is butyl hydroxyto
  • compositions of the present invention can contain other ingredients so long as the beneficial, pediculicidal and ovicidal nature of the invention is not adversely affected and so long as the effectiveness of the invention is not altered.
  • embodiments of the present invention can contain antimicrobial agents such as methylparaben and propylparaben.
  • antimicrobial agents such as methylparaben and propylparaben.
  • Other examples include the addition of a fragrance for aesthetic qualities, addition of propellants for aerosol type formulations, addition of foaming or conditioning agents.
  • Those skilled in the art realize the vast amount of additional excipients that could be added to the formulation for improved aesthetics or delivery of he product to the host.
  • composition of the present invention can be used in different forms, such as a liquid body soap or a shampoo.
  • the present invention takes the form of a gel, an emulsion, a lotion, an aerosol spray, a mousse, or a cream.
  • the composition of the present invention is in the form of a surfactant based gel.
  • the invention also provides a method of treating an individual having a parasite infestation comprising administering to the infestation an insecticide composition as described above.
  • the composition of the present invention is effective as an insecticide intended for killing and removing lice from humans.
  • Varied treatment regimens are contemplated as being within the method of treatment provided by this invention. Treatment regimens can vary from a single administration to repeated administrations over long time periods. The various possible treatment regimens would be apparent to one skilled in the art based on the invention disclosed herein and are intended to be encompassed in the scope and spirit ofthe claims.
  • This method includes applying the composition to the infested area, such as the hair of an individual with a lice infestation.
  • the composition is left on the hair for a period of time referred to as the residence or exposure time.
  • the residence time can vary as needed to produce effective results.
  • the residence time can be as long as 24 hours and as short as several seconds.
  • the residence time is between 1 and 30 minutes. More preferably, the residence time is between approximately 5 and 20 minutes.
  • the composition is rinsed from the area of infestation.
  • any suitable nit comb can be used in the described method of use ofthe composition ofthe present invention.
  • a suitable nit comb may be made of various materials such as metal and plastic.
  • Metal teeth are sturdier and stiffer than those composed of materials such as plastic. Nit combs with metal teeth therefore often last longer than nit combs without metal teeth.
  • the number of teeth and the diameters of the teeth can also vary.
  • the spacing between teeth can also vary; however, the teeth should be close enough to one another to remove nits.
  • the distance between teeth should be 0.3mm or less, the generally accepted width of nits attached to human hair.
  • a nit comb such as the ALB006 is used, which is available from Albyn Stonehaven Ltd. (Stonehaven, Scotland).
  • This comb has 62 metal pins arranged side by side which act as the teeth ofthe comb. These pins extend approximately 12.5mm from a plastic piece which acts as the handle of the nit comb.
  • the pins on either end have a diameter of 0.9mm and the 60 inner teeth have a diameter of 0.6mm.
  • the gap between the teeth is 0.3mm.
  • propylene carbonate is not a necessary ingredient to provide the observed synergistic effect of the invention. Additionally, to the inventors' knowledge, there has not been a previous recognition or demonstration of the effectiveness of the present invention at cleansing individuals of pest infestations. One skilled in the art can routinely modify the relative concentrations of these components, and accordingly the ratio of their combination, to yield a functional pesticide composition.
  • Citronella oil is a complex mixture containing components which may ordinarily mask the potential effectiveness ofthe individual purified terpene pesticidal agents, such as citronellyl, citronellol, and citronellal, as disclosed by the present invention. It also appears that a synergistically beneficial effect is achieved in the compositions ofthe present invention.
  • the present invention is intended to be administered topically to infested areas of an individual, such as the hair and scalp or pubic areas.
  • the composition is preferably provided in the form of a liquid or solid, such as shampoo, soap, cream, or lotion.
  • various other complimentary ingredients can be included, such as an antipruritic agent, a pH modifier, or as a general medium.
  • glycerins, glycols, alcohols, lanolins, aloe vera gel may be provided in the composition.
  • the preferred compositions are shampoos and soaps containing ingredients capable of assisting in cleansing individuals of the debris of dead parasites.
  • the composition may also be provided in sun screening, tanning or any other topically applicable products.
  • Other uses ofthe composition are contemplated, such as a pediculicidal and ovicidal spray or fogger for application directly to pests or potentially infested areas.
  • the composition can be provided as a pesticide and cleaning agent for fruits and vegetables.
  • the composition can additionally serve as a parasite repellent for humans, cats, dogs, birds, cattle, or sheep, for example.
  • the composition may also be used as a carpet powder, or as a detergent additive, rinse or spray for clothing, bedding or other fabrics.
  • the composition may also be used as an aerosol bomb or as a room spray. Other such uses would be apparent to one skilled in the art upon contemplating the invention disclosed herein and such uses are intended to be encompassed in the scope and spirit ofthe claims.
  • the in vitro test incorporates human body lice that have been adapted to feed on rabbit blood not human head lice, which feed on human blood. It is plausible that a difference in efficacy could be observed based on the difference in species being tested.
  • lice or nits being treated are completely submerged in the test solution for the entire identified residence time. This method of "application" of the product is drastically different than topical application in vivo. A similar in vivo application would be to submerge a child's hair in the test product. This is obviously not the most practical or safe method of actual application.
  • the application technique for the in vitro ovicidal test method was also amended.
  • ASTM method adult lice were allowed to lay eggs on clipped human hair. Then, ten hair strands, 1 nit attached to each, were taped to an applicator stick. Finally, the applicator stick with hair and nits was submerged in the test solution for the entire identified residence time.
  • the new application method incorporated "tresses" of hair. Each tress was a collection of human hair bundled at one end, and the lice were allowed to lay numerous eggs on these tresses (about 200-300 nits per tress).
  • the tresses were woven into sections of a human hair wig, and the wig was secured to a non-porous solid surface "head.”
  • the test product and a control (water) was applied each section of the wig with a method similar to typical shampooing or applying a cream rinse in under 2 minutes. After application, the product was allowed to remain, undisturbed, in contact for the identified residence time. After the residence time, the wig was rinsed thoroughly (until no visible signs of product remained) with tap water and towel dried.
  • the tresses, with nits, were removed from the wig and incubated under appropriate conditions for 14 days post treatment.
  • Level of hatching is basically a "pass/fail" assessment of penetration. For example, if the product penetrates the nit pore but not the nit membrane (used for regulation of gas transport), the product will collect around the membrane (common with currently marketed products). Therefore, the nit will actually develop and begin to hatch. However, once the nymph has broken the membrane, it is exposed to a certain level of active. If enough active is present, it will kill the nymph while hatching, and this can be documented as a "half hatched" nit. If the nit is exposed but not killed, it could become resistant to future treatment with the compound. This could be one explanation of the documented resistance of human head lice to current actives.
  • Assessment and location of eye spot formation provides a more detailed measurement of penetration.
  • the nits have not developed eyespots. Therefore, if the product completely penetrates inside the nit, it will be killed at the time of exposure and no development will occur. However, if eyespot formation is seen it indicates lack of penetration, and the location ofthe eyespot can even predict the level of penetration.
  • a vehicle with 10.0% and 12.5% strengths of citronellyl acetate was used to assess the ovicidal activity with the new method.
  • the ASTM method resulted in 100% activity for both strengths. While the new method resulted in 96.2% and 98.1% activity respectively, only 53.4% and 72.0% of the nits were undeveloped respectively. Obviously, the new method shows that while the overall effect may be positive (i.e. almost 100%) the underlying ability of the product to penetrate may not correlate with the activity.
  • the formulation was an oil-in-water (O/W) emulsion (instead of a solution, original two-component formulation) and is referenced in US Patent No. 5,902,595.
  • the product was designed as a cream rinse incorporating conditioners in lieu of the surfactant, sodium laureth sulfate. For irritation issues, it was believed that the conditioner might soothe the irritating effects.
  • thickening, emulsifying agents incorporated into the formulation are various grades of CarbopolTM (carbomer), PVP (polyvinylpyrrolidone), Pemulen® (Acrylates/C 10-30 Alkyl Aery late Crosspoly-mer), Klucel HF® (hyroxypropyl cellulose), hydroxyethtyl cellulose, hydroxypropylmethyl cellulose, and each was used individually and in combination with the others. Also, buffer systems (such as sodium acetate trihydrate) and neutralizing agents (such as TEA, triethanolamine) were included as needed. Following is a table summarizing the ingredients and ranges used in the most desired O/W emulsions developed.
  • Pemulen® TR-1 One specific formulation (included in above ranges with 1.75%) Pemulen® TR-1) was tested for stability and in vitro pediculicidal efficacy. This formulation resulted in much greater stability as a single component, but in vitro pediculicidal testing indicated poor efficacy.
  • Clear gel formulations offer many positive attributes. First, they are typically thickened alcoholic solutions. This allows for greater drug uniformity, greater drug loading, greater contact time, and less phase separation. Also, topical gels can incorporate non-aqueous solvents such as glycerin and propylene glycol that also can enhance penetration and possess humectant qualities, which can increase the penetration of the active and help to overcome any irritating effects of other ingredients.
  • non-aqueous solvents such as glycerin and propylene glycol that also can enhance penetration and possess humectant qualities, which can increase the penetration of the active and help to overcome any irritating effects of other ingredients.
  • These new formulations incorporated an antiparasitic compound, citronellyl acetate, as the active purified terpene agent, but citronellol, citronellal, gerianol, and/or nerol can also be used, for example.
  • a short chain organic alcohol was included as a solvent and was used as the diluent. Specific examples of alcohol used are isopropyl alcohol and ethanol.
  • Other non- aqueous solvents were included such as propylene glycol and glycerin.
  • Other anhydrous glycols such as butylene glycol, hexylene glycol, polyethylene glycol, methoxypolyethylene glycol, and their derivatives could be included.
  • antioxidant/radical scavenging agent butyl hydroxytoluene (BHT)
  • BHT butyl hydroxytoluene
  • chelating agents can be added to improve stability since they form complexes with metal ions rendering them unavailable for reaction and/or as a catalyst for other reactions, which usually results in increased stability of the formulation.
  • An example of a possible chelator is EDTA.
  • Some of the new formulations were thickened with alcohol compatible polymers such as hydroxypropyl cellulose (HPC, "Klucel® HF), polyvinylpyrrolidone (PVP), and Pemulen TR-1® and TR-2® (CTFA name: Acrylates/C 10-30 Alkyl Acrylate Crosspoly-mer), hydroxy ethyl cellulose, and hydroxymethylpropyl cellulose.
  • HPC hydroxypropyl cellulose
  • PVP polyvinylpyrrolidone
  • CTFA name Acrylates/C 10-30 Alkyl Acrylate Crosspoly-mer
  • hydroxy ethyl cellulose hydroxymethylpropyl cellulose
  • hydroxymethylpropyl cellulose hydroxymethylpropyl cellulose.
  • Various amounts ofthe thickeners were added to optimize the viscosity ofthe formulation. In theory, this would increase the contact time of the active ingredient with the pest and decrease side effects such as burning of the eyes and mucous membranes (due to a thin product running off
  • Formulation 022800-006A Five specific formulations were developed that possessed the best aesthetic qualities and could be tested for the effect ofthe alcohol selection and viscosity. In general two thin (water like) formulations were made, 1 with ethanol and the other with IPA. The third formulation incorporated ethanol and Klucel® HF as a thickener (resulted in molasses type consistency). Each was tested for in vitro efficacy. Following are the three formulations and in vitro test results: Formulation 022800-006A:
  • the testing shows a twofold increase in pediculicidal effectiveness when IPA is used instead of ethanol (006A vs. 007A). Also, a twofold increase in effectiveness is seen when the thin ethanol formulation is thickened (007A vs. 007B).
  • both the thin IPA formulation and the thickened ethanol formulation are ovicidal and result in basically no development of the nit after exposure.
  • acetic acid was not required to achieve successful ovicidal activity.
  • Inclusion of propylene carbonate had absolutely no effect on the efficacy of the formulations.
  • the in vitro data indicates that an optimized formulation would incorporate IPA as the alcohol, should be thickened, and would not need to incorporate propylene carbonate.
  • the first additional formulations were hybrids of 006A and 007B incorporating IPA as the alcohol and Klucel® HF for thickening.
  • a series ofthe vehicle were made with decreasing amounts of citronellyl acetate.
  • Pemulen TR-1® was incorporated in lieu of Klucel® HF to assess the effect of thickener used.
  • Pemulen TR-1® and TR-2® required for thickening the formulation could be greatly reduced by adding a small amount of a neutralizing agent.
  • neutralizers could be any strong or weak bases, and specific examples are sodium hydroxide, triethanolamine (TEA), and aminomethyl propanol. If the concentration of alcohol is greater than 50%), a more alcohol soluble amine may be required. Specific examples are Quadrol® or Neutrol® (tetra-2-hydroxypropyl ethylene diamine), Ethomeen® C-25 (PEG 15 Cocamine), DIPA (diisopropylamine), or AMP (amino methyl propanol). Following is an example of one formulation developed that incorporated less thickener and a neutralizer:
  • a series of formulations were also prepared for an in vitro dose response study.
  • the dose response study was designed by formulating the clear gel vehicle with 10% IPA and various levels of citronellyl acetate between 0.0 to 10.0%.
  • the formulations were assessed for in vitro pediculicidal activity using the modified methods previously described. All formulations possessed viscosities between 1500-3000 cps, and following is a summary ofthe clear gel formulations that were prepared for the dose response study and the resulting data from the assessments:
  • the ANOVA analysis identified that products incorporating greater than 2.5% citronellyl acetate are capable of statistically significant pediculicidal activity and a statistically significant number of eggs remaining undeveloped. It also identified that products incorporating greater than 1.0% were capable of statistically significant ovicidal activity.
  • the resulting data was statistically modeled using a log (In) fit of the data typical of that observed with dose response data.
  • a screening model was used to identify the minimum dose predicted to elucidate 100% pediculicidal activity in vitro, 100% ovicidal activity in vitro, and 100%) undeveloped eggs in vitro.
  • citronellyl acetate % citronellyl acetate Required citronellyl acetate concentrations were calculated from the predicted values of the prior art and gel formulations. Interestingly for the prior art formulation, no dose could be predicted to yield 100%) activity as the response maximum was 85% activity at 18.4% citronellyl acetate.
  • the lice were submerged for 1 minute and removed but not rinsed for the remainder of the exposure period (10 minutes for all assessments). The lice were rinsed thoroughly with tap water, blotted dry, and placed on a new, dry piece of nylon gauze. The lice were observed for signs of life under a stereomicroscope at various time intervals up to 3 hours after exposure. Lice were classified as "appeared dead” if no physical movement existed or “alive” if the lice were crawling or otherwise physically moving. Percentages were calculated for each classification at each time interval. Following were the results ofthe study:
  • Formulation #3 Surprisingly for formulations #1 and #2, initial observation times indicate a high level of apparent kill, but as time elapsed the lice recovered and lived. Therefore, while these treatments may show efficacy to non-resistant lice, they most likely will not display any efficacy to the resistant ones. However, Formulation #3 (with sodium laureth sulfate, Steol CS-230) apparently overcame the resistance mechanism and resulted in 100% kill. This indicates that the product will most likely be effective against resistant lice in the field. Obviously, the study results identified the surfactant based, clear gel product as the preferred embodiment.
  • This optimized surfactant based formulation was duplicated and used for comparative pre-clinical toxicology assessments. These assessments were performed and results classified identically to those for prior art (add-mix system, US Patent No. 5,902,595) for a direct comparison of skin irritation. For the skin irritation testing, an additional exposure time was assessed for the preferred embodiment. Therefore, the study assessed irritation associated with both a 1 and 4-hour exposure to the test product. The Primary Irritation Index (PII) was calculated at 1 and 4-hour exposures.
  • PII Primary Irritation Index
  • the resulting PIIs were 3.58 for the 1-hour exposure and 4.54 for the 4-hour exposure, both of which classify as a "moderate irritant.”
  • the preferred embodiment resulted in drastically improved dermal irritation profiles as compared to the prior art that resulted in a PII of 6.75 indicating that the product was "severely irritating”.
  • a variation of the preferred embodiment was prepared with one of the chirally pure terpenes, R- or S-citronellol.
  • the formulations were prepared and tested for in vitro pediculicidal activity using lab lice and the 5 second immersion technique. Interestingly, both formulations resulted in 100%) activity.
  • a significant difference in the symptoms of exposure and manner of death was observed between the two groups of lice. Immediately after rinsing, there was no difference between the groups. In both cases 3 to 4 lice were beginning to show movement, and some others were inactive but showed gut movement. After 60 minutes, physical signs of exposure began to differentiate.
  • the lice exposed to S-citronellol were basically walking as normal, but 10 lice were showing tonic-clonic spasms similar to that seen for lice exposed to permethrin or other pyrethroids. Only 1 of the lice exposed to R-citronellol appeared alive and normal, 4 others were trying to walk, but the rest were completely immobilized. After 180 minutes, 4 four lice exposed to R-citronellol were lying down with "waggling" limbs and the rest remained completely immobilized. For the ones treated with S- citronellol, 2 were lying down with "waggling" limbs, 1 louse walking uncomfortably with stiff limbs, and the remainder were immobile. While both pure enantiomers eventually exhibited 100% pediculicidal activity, the symptoms and physical characteristics after exposure varied drastically.

Abstract

L'invention concerne une composition pédiculicide et ovicide dotée d'une extraordinaire efficacité létale, qui peut également s'utiliser pour l'élimination de parasites, tels que les poux. La composition pédiculicide et ovicide contient un agent terpène purifié, tel que le citronellal, le citronellol, le citronellyle ou un mélange de ces derniers, un alcool à chaine courte, et un co-solvant non aqueux et/ou un composant tensio-actif. La composition utilise de préférence un acétate de citronellyle comme principe actif. Les compositions peuvent être administrées topiquement à des humains, à des animaux ou à toute zone infestée.
PCT/US2001/016367 2000-05-19 2001-05-21 Composition de traitement contre les parasites WO2001089503A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2001274877A AU2001274877A1 (en) 2000-05-19 2001-05-21 Pest treatment composition
US10/276,657 US7282211B2 (en) 2001-05-21 2001-05-21 Pest treatment composition
US11/775,641 US7902256B2 (en) 2000-05-19 2007-07-10 Pest treatment composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20584300P 2000-05-19 2000-05-19
US60/205,843 2000-05-19

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10276657 A-371-Of-International 2001-05-21
US11/775,641 Continuation US7902256B2 (en) 2000-05-19 2007-07-10 Pest treatment composition

Publications (1)

Publication Number Publication Date
WO2001089503A1 true WO2001089503A1 (fr) 2001-11-29

Family

ID=22763861

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/016367 WO2001089503A1 (fr) 2000-05-19 2001-05-21 Composition de traitement contre les parasites

Country Status (2)

Country Link
AU (1) AU2001274877A1 (fr)
WO (1) WO2001089503A1 (fr)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6663876B2 (en) 2002-04-29 2003-12-16 Piedmont Pharmaceuticals, Llc Methods and compositions for treating ectoparasite infestation
WO2005012210A2 (fr) * 2003-08-01 2005-02-10 Dr. Andre Rieks - Labor Für Enzymtechnologie Gmbh Preparations a activite antimicrobienne
WO2005013930A1 (fr) * 2003-08-02 2005-02-17 Lrc Products Limited Composition antiparasite
WO2005077175A1 (fr) * 2004-02-11 2005-08-25 Bretts Pty Limited Regulation de pesticide
US8012498B2 (en) 2004-07-12 2011-09-06 Sandhya Goyal Topical gel formulation comprising organophosphate insecticide and preparation thereof
US8158139B2 (en) 2004-07-12 2012-04-17 Taro Pharmaceuticals North America, Inc. Topical gel formulation comprising organophosphate insecticide and preparation thereof
US8536155B2 (en) 2005-07-06 2013-09-17 Taro Pharmaceuticals North America, Inc. Process for preparing malathion for pharmaceutical use
US20150093426A1 (en) * 2013-09-30 2015-04-02 Fmc Corporation Foam formulations and apparatus for delivery
WO2017198241A1 (fr) * 2016-05-19 2017-11-23 Vakos Xt A.S. Agent anti-poux
CN108812690A (zh) * 2018-06-01 2018-11-16 江苏敖广日化集团股份有限公司 一种除螨制剂及其制备方法
US10631535B2 (en) 2014-06-24 2020-04-28 Fmc Corporation Foam formulations and emulsifiable concentrates
CN111807868A (zh) * 2020-06-22 2020-10-23 佛山欧神诺陶瓷有限公司 一种防螨除螨瓷砖及其制备方法
US11632959B2 (en) 2015-12-23 2023-04-25 Fmc Corporation In situ treatment of seed in furrow

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4229707A1 (de) * 1992-09-05 1994-03-10 Beiersdorf Ag Germicide Wirkstoffkombinationen
JPH07116237A (ja) * 1993-10-22 1995-05-09 Mitsubishi Materials Corp 男子トイレ用固形消臭剤
US5783202A (en) * 1995-03-14 1998-07-21 Soltec Research Pty. Ltd. Pediculicidal mousse composition for killing head lice
US5977186A (en) * 1998-01-27 1999-11-02 Ximed Group Plc Terpene treatments for killing lice and lice eggs

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4229707A1 (de) * 1992-09-05 1994-03-10 Beiersdorf Ag Germicide Wirkstoffkombinationen
JPH07116237A (ja) * 1993-10-22 1995-05-09 Mitsubishi Materials Corp 男子トイレ用固形消臭剤
US5783202A (en) * 1995-03-14 1998-07-21 Soltec Research Pty. Ltd. Pediculicidal mousse composition for killing head lice
US5977186A (en) * 1998-01-27 1999-11-02 Ximed Group Plc Terpene treatments for killing lice and lice eggs

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI 10 March 1994 Derwent World Patents Index; AN 1994-084334, XP002945698, KLEIN ET AL.: "Germicidal combinations comprising imidazole deriv. and lantibiotic" *
DATABASE WPI 9 May 1995 Derwent World Patents Index; AN 1995-202890, XP002945699, "Solid deodorant for use in men's toiletries" *

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6663876B2 (en) 2002-04-29 2003-12-16 Piedmont Pharmaceuticals, Llc Methods and compositions for treating ectoparasite infestation
WO2005012210A2 (fr) * 2003-08-01 2005-02-10 Dr. Andre Rieks - Labor Für Enzymtechnologie Gmbh Preparations a activite antimicrobienne
WO2005012210A3 (fr) * 2003-08-01 2005-04-21 Andre Rieks Labor Fuer Enzymte Preparations a activite antimicrobienne
WO2005013930A1 (fr) * 2003-08-02 2005-02-17 Lrc Products Limited Composition antiparasite
GB2404587B (en) * 2003-08-02 2008-05-14 Ssl Int Plc Parasiticidal composition
WO2005077175A1 (fr) * 2004-02-11 2005-08-25 Bretts Pty Limited Regulation de pesticide
US8012498B2 (en) 2004-07-12 2011-09-06 Sandhya Goyal Topical gel formulation comprising organophosphate insecticide and preparation thereof
US8158139B2 (en) 2004-07-12 2012-04-17 Taro Pharmaceuticals North America, Inc. Topical gel formulation comprising organophosphate insecticide and preparation thereof
US20120172338A1 (en) * 2004-07-12 2012-07-05 Sandhya Goyal Topical gel formulation comprising organophosphate insecticide and its preparation thereof
US8957238B2 (en) 2005-07-06 2015-02-17 Taro Pharmaceuticals North America, Inc. Process for preparing malathion for pharmaceutical use
US8536155B2 (en) 2005-07-06 2013-09-17 Taro Pharmaceuticals North America, Inc. Process for preparing malathion for pharmaceutical use
US20150093426A1 (en) * 2013-09-30 2015-04-02 Fmc Corporation Foam formulations and apparatus for delivery
US10785974B2 (en) 2013-09-30 2020-09-29 Fmc Corporation Foam formulations and apparatus for delivery
US10834921B2 (en) * 2013-09-30 2020-11-17 Fmc Corporation Foam formulations and apparatus for delivery
US11330815B2 (en) 2013-09-30 2022-05-17 Fmc Corporation Foam formulations and apparatus for delivery
US10631535B2 (en) 2014-06-24 2020-04-28 Fmc Corporation Foam formulations and emulsifiable concentrates
US11632959B2 (en) 2015-12-23 2023-04-25 Fmc Corporation In situ treatment of seed in furrow
WO2017198241A1 (fr) * 2016-05-19 2017-11-23 Vakos Xt A.S. Agent anti-poux
CN108812690A (zh) * 2018-06-01 2018-11-16 江苏敖广日化集团股份有限公司 一种除螨制剂及其制备方法
CN111807868A (zh) * 2020-06-22 2020-10-23 佛山欧神诺陶瓷有限公司 一种防螨除螨瓷砖及其制备方法

Also Published As

Publication number Publication date
AU2001274877A1 (en) 2001-12-03

Similar Documents

Publication Publication Date Title
US7902256B2 (en) Pest treatment composition
US4518593A (en) Insecticide composition for use in the form of a shampoo
US8293286B2 (en) Natural compositions for killing parasites on a companion animal
US5227163A (en) Lice-repellant compositions
EP0932338B1 (fr) Composition pesticide et procede d'utilisation associe
AU2006315084B2 (en) Pediculicide/ovicide composition
WO2001089503A1 (fr) Composition de traitement contre les parasites
RU2113119C1 (ru) Средство для отпугивания насекомых
GB1593601A (en) Insecticide composition
WO2020176697A1 (fr) Compositions repoussant les insectes et leurs procédés de fabrication
CA2059414A1 (fr) Compositions anti-poux
US6596291B2 (en) Compositions and methods for treating surfaces infected with ectoparasitic insects
US6350724B1 (en) Lice removing composition
US20220151915A1 (en) Insect repellent compositions and methods of use
JPH08208408A (ja) 持続性シャンプー剤による寄生虫の残留コントロール
WO2001012173A1 (fr) Composition a faible teneur pour traiter des parasites et procede associe
JPH09169606A (ja) ウンデシレン酸誘導体のシラミ撲殺剤としての使用
Patyk Practical evaluation of insecticides and their application
JP2021050170A (ja) シラミ駆除剤
US20020022014A1 (en) Compositions and methods for delousing
RU2048804C1 (ru) Шампунь для борьбы с педикулезом
Patyk Practical evaluation of insecticides and their application. III Symposium on Medical and Veterinary Acaroentomology, Gdansk 25-28 September 1975
WO2021009888A1 (fr) Pédiculicide
WO2002024182A1 (fr) Formulation contre les ectoparasites
MXPA99001095A (en) Pesticidal composition and method of use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 10276657

Country of ref document: US

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP